tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Income Statement

Compare
118 Followers

Dermata Therapeutics Income Statement

Last quarter (Q3 2024), Dermata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dermata Therapeutics's net income was $-3.17M. See Dermata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -322.00$ -1.35K
Operating Expenses
$ 8.04M$ 9.67M$ 7.86M$ 3.17M$ 4.47M
Depreciation and Amortization
$ 8.04M$ 9.67M$ 322.00$ 322.00$ 1.35K
EBITDA
$ 247.22K$ 0.00$ -7.86M$ -3.17M$ -4.47M
Operating Income
$ -8.04M$ -9.67M$ -7.86M$ -3.17M$ -4.47M
Other Income/Expenses
$ 247.22K$ 63.57K$ -45.61K$ -63.68K$ -250.75K
Pretax Income
$ -7.79M$ -9.61M$ -7.90M$ -3.24M$ -4.72M
Net Income
$ -7.79M$ -9.61M$ -7.95M$ -3.43M$ -4.97M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -40.18$ -13.92$ -15.27$ -6.60$ -9.55
Diluted EPS
$ -39.98$ -13.92$ -15.27$ -6.60$ -9.55
Weighted Average Shares Outstanding
194.00K 690.67K 520.54K 520.54K 520.54K
Weighted Average Shares Outstanding (Diluted)
194.96K 690.67K 520.54K 520.54K 520.54K
Currency in USD

Dermata Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis